CROI 2010: Welcome to the Treatment Update Program

Please click on the video below to begin the Playlist for the Treatment Update 2010. The First Panel: Anti-Retrovirals, will play, followed by the Metabolic Issues and HIV Panel and then the Hepatitis Co-Infection Panel. There are links after the video below to play each video independently, so you can choose which panel to watch. If you have to restart a video - please choose from this list and use the slider bar on the bottom to return to the place you where.
Expand the video to full screen by clicking the little TV icon on the bottom right of the picture!

First Panel: Anti-Retrovirals
Second Panel: Metabolic Issues and HIV
Third Panel: Hepatitis Co-Infection

After you are finished watching these video please click on this link to take a short survey

There are over 50 video interviews/panels on this site, choose a topic on the lower right panel.

CROI 2010: Clinical Applications & Overview of the Conference by Joel Gallant, MD

Joel Gallant. MD gives a practical clinical overview of the highlights from the conference.
Trial results, studies, drug development, and new treatment options....

Please After Watching a Program(s) - 
Click here to take a short survey.  Thank you!

CROI 2010: African-American Issues in HIV from the 2010 CROI - panel discussion

CROI 2010: Issues specific to women, advances in HIV epidemiology, treatment and prevention research

Yasmin Halima, Director of the Global Campaign for Microbicides discusses with experts at CROI 2010, advances in research on HIV prevention and treatment as it impacts on women.

Moderator: Yasmin Halima, Director of the Global Campaign for Microbicides, Washington DC and Professor at the American University, Washington DC, USA.

Carl Dieffenbach, Director, Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Glenda Gray, Professor, Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa.
Sharon Hillier, Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Director, Center of Excellence in Women's Health, Magee-Womens Hospital of UPMC, Pittsburgh, PA, USA.

Click her for more information on Path/Global Campaign for Microbicides 

Click here to take a short survey.  Thank you!

CROI 2010: NADIR ALLA CROI (in Italian)

CROI 2010: Survival of Hepatitis C in Syringes

Robert Heimer, Yale School of Medicine,  discusses the Survival of HCV in Syringes, and the implication for HCV transmission among Injection Drug Users.

CROI 2010: Immune Based Therapy Treatments in HIV

CROI 2010: Cal Cohen and Rick Elion give their take home messages

CROI 2010: Aging and HIV

This panel, moderated by Jules Levin covers many important topics around aging with HIV.
Including: Heart Disease, Bone Health, Cancers, and Renal Function.

CROI 2010: Neurology issues in HIV

Kevin Robertson

CROI 2010: Mouse to Man? XMRV and Human Disease

Stephen Goff, Columbia Univ Coll of Physicians & Surgeons, New York, NY, US

CROI 2010: Fatty Liver Disease in HIV

Jacqueline Capeau, Inserm, University of Paris
Hepatic Steatosis, Pathogenesis, and Management

CROI 2010: Pharmacogenetics - Upcoming Applications to Patient CARE

Andrew Owen,  Univ of Liverpool.

CROI 2010: Hepatitis C (HCV)

Sustained Virological Response to Interferon Plus Ribavirin Reduces HIV Progression and
Non–Liver-Related Mortality in Patients Coinfected With Human Immunodeficiency Virus and
Hepatitis C Virus
Juan Berenguer, Hosp Univ Gregorio Marañon, Madrid, Spain

CROI 2010: John Coffin on Basic Science

John Coffin, Tufts University, talks about the Basic Science at the CROI 2010 in San Francisco

CROI 2010: Panel in French

CROI 2010: The Future of the TB and MDRTB: Research and Treatment

Diane Havlir,  San Francisco General Hospital

CROI 2010: Treatment as Prevention

Put Your Money Where Your Model Is: ART for the Prevention and Treatment of HIV/AIDS
Brian Williams, South African Ctr for Epidemiological Modelling and Analysis, Stellensbosch

CROI 2010: Disproportionate Impact of HIV in Communities of Color

The US Epidemic—Disparities in HIV Disease, Care, and Outcomes
Kimberly Smith, Rush Univ Med Ctr, Chicago, IL, US

CROI 2010: Mother to Child Transmission - Use of Nevirapine

James McIntyre

CROI 2010: Limb Fat & Bone Mineral Density

Bone and Limb Fat Outcomes of ACTG A5224s, a Substudy of ACTG A5202: A
Prospective, Randomized, Partially Blinded Phase III Trial of Abacavir/Lamivudine or TenofovirDF/Emtricitabine with Efavirenz or Atazanavir/Ritonavir for Initial Treatment of HIV-1 Infection.

Grace A McComsey, Case Western Reserve Univ, Cleveland, OH, US

CROI 2010: Drug Resistent TB

CROI 2010: Debate español de la gripe H1N1

El Dr. Estaban Martinez de el Hospital Clinia en Barcelona,Espana discutio sus resultados en de su estudio acerca de la H1N1 influenza con adultos con VIH, Aunque los adultos en el estudio con VIH tuvieron las mismas symtomas que personas sin VIH, en este estudio parace que los pacietes no se enfermaban mas que las personas negativas, No hubo muertes en el grupo positivo. De todos modos, los adultos con VIH todavian se deben cuidar y tomar las mismas precuaciones como el resto de la poplacion.

CROI 2010: Community Involvement in AIDS Research

Lynda Dee, from the AIDS Treatment Activists Coalition was honored to present the first annual Marty Delaney lecture. Martin Delaney was a long-time AIDS activist/advocate, and founder of Project Inform. Martin died shortly before the 2009 CROI on January 23, 2009 from liver Cancer.

To hear more stories from the life of Martin Delaney from Activists and Doctors:

CROI 2010: Vaccine Development - Explanation & Challenges

Dennis Burton, Scripps Res Inst, La Jolla, CA, on the abstract on Conserved Neutralizing Targets on the HIV-1 Envelope Spike.

CROI 2010: The US Epidemic— Disparities in HIV Disease, Care, and Outcomes

Kimberly Smith,
Rush Univ Med Ctr,

CROI 2010: Once Daily Next Generation Integrase Inhibitor

Discussion around GlaxoSmithKline's new once daily Integrase Inhibitor, S/GSK1349572.
S/GSK1349572 is a novel integrase inhibitor with potent in vitro anti-HIV activity, an in vitro resistance profile different from those of other integrase inhibitors, and favorable preclinical safety and pharmacokinetics (PK).

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: Researcher Bruce Walker, MD on elite controllers and nonprogressors

Bruce Walker, M.D., Director of Ragon Institute and Principal Investigator, International HIV Controller Study, Boston, Massachusetts, discusses his early involvement with clinical research and his fascination with the HIV-infected community known as 'HIV Controllers'.

Interviewed by Loreen Willenberg from the Zephyr L.T.N.P Foundation.

CROI 2010: Women as HIV Controllers

Barbara Shacklett, Ph.D., University of California at Davis, discusses her work with HIV controllers and announces the launch of three new clinical studies on women (controllers) in the Bay Area of Northern California.

Interviewed by Loreen Willenberg from the the Zephyr L.T.N.P Foundation, Inc.

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: Comparison of Immunologic and especially Virologic Failure Criteria

Holly Rawizza with the Harvard PEPFAR group discusses using viral load monitoring to determine treatment failure.

CROI 2010: HIV, Inflammation, and Cardiovascular Disease

Priscilla Hsue, University of California, SF

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: ART and the risk of heterosexual HIV transmission

ART and the Risk of Heterosexual HIV-1 Transmission in HIV-1 Serodiscordant African Couples.

CROI 2010: Engineering Immunity against HIV-1

Pamela Bjorkman, California Institue of Technology, discusses concepts in developing a vaccine against HIV.

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: AIDS Vaccines

Alan Bernstein, executive director, Global HIV Vaccine Enterprise, Seattle, Washington --
discusses some of the issues around what it would take to make a successful vaccine through broadly neutralizing antibodies.

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: Growing Up with HIV

Growing up with HIV: Consequences of a lifetime of ART.
Grace Aldrovandi, Children's Hospital of Los Angeles discusses what happens when a child grows up HIV+.

CROI 2010: AIDS Prevention today

Panel Discussion on February 16th with:
Dana Van Gorder, Executive Director, Project Inform
Jen Hecht, Education Director, Stop AIDS Project
Dr. Susan Buchbinder, Director of HIV Research Division, SF Dept. of Public Health

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: Peter Hunt on Elite Controllers

Peter Hunt, M.D., University of California at San Francisco discusses HIV-related inflammation issues and their potential effects in controllers.

CROI 2010: Summary of some of the important topics by the Conference Chair

John Mellors, MD, summarized the activities that will be happening this week at the 2010 CROI.

CROI 2010: Adherence

Pre-Conference Community Panel

ADHERENCE: Why It Matters, and Strategies that Help
Including: Dosing to maintain proper drug levels, resistance concerns, managing your medications and setting goals.

Please After Watching a Program(s) -
Click here to take a short survey. Thankyou!

CROI 2010: Drug Development

Pre-Conference Community Panel

DRUG DEVELOPMENT: Understanding HIV Drug Development – From Discovery to Approval and Beyond
Including: Drug development timeline and process issues.

Speaker Index

Alphabetical list of Speakers: (click on the name to go to the video page)
Grace Aldrovandi Growing Up with HIV
Alan Bernstein AIDS Vaccines
Pamela Bjorkman Engineering Immunity against HIV-1
Susan Bookbinder, AIDS Prevention Today
John Coffin Tuesday Press Conference
Paul Dalton Adherence DRUG DEVELOPMENT
Anthony Fauci Tuesday Press Conference
Eric Goosby Tuesday Press Conference
Jennifer Hecht Tuesday Press ConferenceAIDS Prevention Today
Peter Hunt On Elite Controllers
Priscilla Hsue HIV, Inflammation, and Cardiovascular Disease
John Mellors, MD Summary by Conference Chair , Tuesday Press Conference
Holly Rawizza Comparison of Immunologic and especially Virologic Failure Criteria
Barbara Shacklett, Ph.D Women as Elite Controllers
Kimberly Smith, The US Epidemic— Disparities in HIV Disease, Care, and Outcomes
Suniti Solomon Tuesday Press Conference
Dana Van Gorder Tuesday Press ConferenceAIDS Prevention Today
Bruce Walker, M.D Elite Controllers and Nonprogressors
Brian Williams  Tuesday Press Conference

CROI 2010: Women's Issues